G. Himmler

Neutralising Effects of Different Antibodies on Clostridioides difficile Toxins TcdA and TcdB in a Translational Approach
20236 citationsauthor #7
Efficient production of recombinant Secretory IgA against Clostridium difficile toxins in CHO-K1 cells.
202112 citationsauthor #16
Highly sensitive quantification of human total VEGF-A with a novel ELISA
20200 citationsauthor #5
Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
202013 citationsauthor #3
Novel VEGF-A ELISA allows sensitive quantification of human total bioactive VEGF-A
20200 citationsauthor #5
Development and validation of a novel ELISA for the detection of intact FGF23 in serum and plasma
20190 citationsauthor #4
A high-sensitivity enzyme immunoassay for the quantification of soluble human semaphorin 4D in plasma.
20195 citationsauthor #5
Bioactive Sclerostin: better analyte definition in the measurement of bone remodeling
20190 citationsauthor #5
Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study
201918 citationsauthor #5
SP283DESCRIPTION OF A VALIDATED SANDWICH ELISA FOR THE QUANTIFICATION OF TOTAL SOLUBLE HUMAN NEUROPILIN-1
20190 citationsauthor #5
Sandwich ELISA for the Quantification of Soluble Human Semaphorin 4D, a factor promoting skeletal metastases
20190 citationsauthor #6
Detection of intact FGF23 using a novel well-characterized ELISA
20190 citationsauthor #4
Characterization of a sandwich ELISA for quantification of total human soluble neuropilin‐1
20194 citationsauthor #5
SP044 ROLE OF CELL DEATH IN NEPHROCALCINOSIS: AN IN VITRO STUDY OF HK-2 CELLS
20180 citationsauthor #25
Dynamics of serum C-type natriuretic peptide as predictor for preeclampsia.
20186 citationsauthor #3
Characterization of a sandwich ELISA for the quantification of all human periostin isoforms
201814 citationsauthor #6
FP282DEVELOPMENT OF AN IMMUNOASSAY THAT REVEALS ALTERED URINARY VANIN-1 IN HUMAN WITH KIDNEY DISEASE
20180 citationsauthor #5
SP046NEW BIOACTIVE ANGIOPOIETIN-2 ELISA ALLOWS ACCURATE QUANTIFICATION OF ANGIOGENIC FACTOR ANGIOPOIETIN-2 IN KIDNEY DISEASE
20180 citationsauthor #4
Secretory immunoglobulin purification from whey by chromatographic techniques.
201712 citationsauthor #3
A nonchromatographic process for purification of secretory immunoglobulins from caprine whey
20175 citationsauthor #2
SP186NOVEL ELISA FOR THE MEASUREMENT OF HUMAN SEMAPHORIN 4D IN DIALYSIS PATIENTS
20170 citationsauthor #3
A novel highly specific ELISA allows the measurement of human periostin in plasma and serum
20160 citationsauthor #3
Detection of nepoviruses in ligneous grapevine material by using IC/PCR
20153 citationsauthor #2
Secretory immunoglobulin deficiency as a potential target for therapy
20140 citationsauthor #1
Modular Antibody Engineering: Antigen Binding Immunoglobulin Fc CH3 Domains as Building Blocks for Bispecific Antibodies (mAb2)
20131 citationsauthor #6
Phase I Dose Escalation Study with the Lewis Y Carbohydrate Specific Humanized Antibody IGN 311
20120 citationsauthor #11
Phase I Dose Escalation Study with the Lewis Y Carbohydrate Specific Humanized Antibody IGN311
20116 citationsauthor #11
Presentation of binding agents
20080 citationsauthor #1
Procedure for manufacturing immunglobulines
20070 citationsauthor #1
Method of modifying T cell receptor
20070 citationsauthor #1
multivalent immunoglobulins modified structural loop region
20070 citationsauthor #2
Multivalent modified immunoglobulins in the structural loop region
20070 citationsauthor #2
A method for manipulation of immunoglobulins
20060 citationsauthor #1
Synthetic immunoglobulin domains properties modified in different regions of the molecule regions complementarity determining link.
20060 citationsauthor #1
Domains of synthetic immunoglobulins with binding properties modified regions of the molecule different regions complementarity determining
20060 citationsauthor #1
Qualification and application of a surface plasmon resonance-based assay for monitoring potential HAHA responses induced after passive administration of a humanized anti Lewis-Y antibody.
200625 citationsauthor #5
Peptide arrays for the determination of humoral responses induced by active immunization with a monoclonal antibody against EpCAM.
20064 citationsauthor #5
Synthetic immunoglobulin domains with in regions of the molecule which differ from the complementarity determining regions modified binding properties
20060 citationsauthor #3
Synthetic immunoglogulindomæner with binding properties that are modified in the regions of the molecule and which is different from the complementarity determining regions
20060 citationsauthor #3
Improved Effector Functions of a Therapeutic Monoclonal
20053 citationsauthor #10
A randomized placebo-controlled phase II study with the cancer vaccine candidate IGN101 in patients with epithelial cancers
20053 citationsauthor #1
SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTn.
200512 citationsauthor #6
A multicenter phase II, open-label trial of multiple doses of cancer vaccine candidate IGN101 to evaluate efficacy against disseminated tumor cells in blood
20053 citationsauthor #2
Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering.
200593 citationsauthor #10
Chapter 26 – Tumor Cells
20050 citationsauthor #2
Heterogeneous Alterations in Human Alloimmunity Associated with Immunization
200520 citationsauthor #8
Coat protein gene sequence of an Austrian isolate of grapevine fanleaf virus
20058 citationsauthor #3
A Randomized Placebo-Controlled Phase II Study with the Cancer Vaccine IGN101 in Patients with Epithelial Cancers
20044 citationsauthor #6
A Phase I Trial of a Monoclonal Antibody Directed to Lewis Y
20041 citationsauthor #10
A randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial solid organ tumors (IGN101/2-01).
200414 citationsauthor #5
Increased effector functions of a monoclonal antibody by glycoform engineering
20041 citationsauthor #10
Immunization of Rhesus monkeys with a conjugate vaccine IGN402 induces immune responses against carbohydrate and protein antigens, and cancer cells
20042 citationsauthor #9
Anticorps n-glycosyle
20040 citationsauthor #2
Anticorps immunogene recombine
20040 citationsauthor #2
A phase Ib trial of an anti-idiotypic vaccine for Lewis Y (IGN 301) administered subcutaneously in patients with refractory solid tumors
20043 citationsauthor #6
45th Annual Meeting of the Austrian Society of Surgery, Klagenfurt, June 10–12, 2004
20040 citationsauthor #4
Immunotherapy of malignant diseases – developments and prospects
20041 citationsauthor #2
Using antibodies in a very low dose for vaccination against cancer
20040 citationsauthor #2
Inhibition of signaling via erbB-receptors by antibodies that target the Lewis Y-antigen
20040 citationsauthor #5
Antibodies Directed against Lewis-Y Antigen Inhibit Signaling of Lewis-Y Modified ErbB Receptors
200464 citationsauthor #5
Improved Lytic Potential of a Therapeutic Monoclonal Antibody by Glycoform Engineering
20041 citationsauthor #4
Oriented EpCAM presentation improves detection of anti EpCAM antibodies
20040 citationsauthor #10
A phase Ib trial of an anti-idiotypic vaccine for Lewis Y (IGN 301) administered subcutaneously in patients with refractory solid tumors.
20040 citationsauthor #6
Anticorps monoclonal immunogene
20030 citationsauthor #3
Fully "Recombinant Enzyme-Linked Immunosorbent Assays" Using Genetically Engineered Single-Chain Antibody Fusion Proteins for Detection of Citrus tristeza virus.
200038 citationsauthor #5
Improved detection of Beet necrotic yellow vein virus in aDAS ELISA by means of antibody single chain fragments (scFv) which wereselected to protease-stable epitopes from phage display libraries
200010 citationsauthor #8
anti-idiotypic antibodies use as cancer vaccines.
20000 citationsauthor #2
A scFv-alkaline phosphatase fusion protein which detects potato leafroll luteovirus in plant extracts by ELISA.
199757 citationsauthor #6
Abstracts of presentations on plant protection issues at the xth international congress of virology
19970 citationsauthor #70
Procede d'amplification sans transcription d'acides nucleiques
19960 citationsauthor #1
pDAP2: a vector for construction of alkaline phosphatase fusion-proteins.
199640 citationsauthor #5
Expression of antibody single-chain fragments with specificities to structural and nonstructural proteins of beet necrotic yellow vein virus in plants: an alternative approach to produce virus resistant plants.
19960 citationsauthor #4
A process for the transcription-free amplification of nucleic acids
19960 citationsauthor #1
SEQUENCES OF RIBOSOMAL GENES AND INTERNAL TRANSCRIBED SPACERS MOVE THREE PLANT PARASITIC FUNGI, EREMOTHECIUM ASHBYI, ASHBYA GOSSYPII, AND NEMATOSPORA CORYLI, TOWARDS SACCHAROMYCES CEREVISIAE
199532 citationsauthor #4
Peptide having antibody inducing function to neutralize genetically divergent hiv-1 isolate
19930 citationsauthor #1
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
19931,075 citationsauthor #6
Amino-acid sequence comparison of nepovirus coat proteins
19929 citationsauthor #2
Cloning and Expression of an HIV‐1 Specific Single‐Chain Fv Region Fused to Escherichia coli Alkaline Phosphatase a
199117 citationsauthor #3
Expression of the plum pox virus coat protein gene in Nicotiana clevelandii.
19905 citationsauthor #8
Nucleotide sequence of AMV-capsid protein-gene.
199014 citationsauthor #2
Detection of the trans activity of the plum pox virus NIa-like protease in infected plants.
19907 citationsauthor #1
In vitro propagation of apple and aspects of setting up a gene bank.
19900 citationsauthor #8
Engineered gene for Escherichia coli alkaline phosphatase for the construction of translational fusions.
199017 citationsauthor #3
Development of plasmids for the preparation of nucleic acid probes specific for plum pox virus.
19900 citationsauthor #1
Construction of cDNA of arabis mosaic virus and its use for diagnosis.
19891 citationsauthor #2
The complete nucleotide sequence of plum pox virus RNA.
1989227 citationsauthor #6
Stopping the DNA polymerase activity at a specific site with a dideoxyoligonucleotide: selective labelling of single stranded circular DNA.
19890 citationsauthor #2
Efficient transformation of Agrobacterium spp. by electroporation.
1989212 citationsauthor #7
REGENERATION OF SHOOTS FROM LEAF DISCS AND STEM MICROCUTTINGS OF FRUIT TREES AS A TOOL FOR TRANSFORMATION
198918 citationsauthor #5
Goldlabelled-immunosorbent electron microscopy with plum pox virus specific monoclonal antibodies.
19890 citationsauthor #1
Expression of the plum pox virus coat protein region in Escherichia coli
19891 citationsauthor #2
Early screening for anti-plum pox virus monoclonal antibodies with different epitope specificities by means of gold-labelled immunosorbent electron microscopy.
19889 citationsauthor #1
Self-hybridization of hybridomas leads to stabilization of clones and increased yield of monoclonal antibodies.
19875 citationsauthor #5
Screening for monoclonal antibodies with covalently linked antigen.
19870 citationsauthor #4
Cross flow diafiltration of serum with basal medium suitable for growth of hybridomas, sterilization and protein reduction.
19871 citationsauthor #4
Electroporative gene transfer (electrotransfection): A method for strain improvement of animal cells
19875 citationsauthor #5
Isoelectric precipitation and gel chromatography for purification of monoclonal IgM
198717 citationsauthor #4
A laboratory fermentor for agarose immobilized hybridomas to produce monoclonal antibodies.
198511 citationsauthor #1
Production kinetics of monoclonal antibodies.
198527 citationsauthor #3
Monoclonal ELISA for the determination of BNYV-virus.
19851 citationsauthor #3

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT